urocanic acid has been researched along with Dermatitis, Allergic Contact in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslam, I; Feldman, SR; Sandoval, LF | 1 |
| Bucana, CD; Kripke, ML; Moodycliffe, AM; Norval, M; Ullrich, SE | 1 |
| Bos, JD; Kammeyer, A; Meinardi, MM; Teunissen, MB | 1 |
1 review(s) available for urocanic acid and Dermatitis, Allergic Contact
| Article | Year |
|---|---|
What's new in the topical treatment of allergic skin diseases.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Calcineurin Inhibitors; Dermatitis, Allergic Contact; Dermatitis, Atopic; Evidence-Based Medicine; Humans; Lipoxins; Randomized Controlled Trials as Topic; Skin; Urocanic Acid | 2014 |
1 trial(s) available for urocanic acid and Dermatitis, Allergic Contact
| Article | Year |
|---|---|
cis-urocanic acid is not useful as an immunosuppressive agent in the treatment of human allergic contact dermatitis.
Topics: Administration, Topical; Allergens; Dermatitis, Allergic Contact; Humans; Immunosuppressive Agents; Patch Tests; Stereoisomerism; Urocanic Acid | 1996 |
1 other study(ies) available for urocanic acid and Dermatitis, Allergic Contact
| Article | Year |
|---|---|
Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
Topics: Adoptive Transfer; Animals; Antibodies, Monoclonal; Antigen-Presenting Cells; Dermatitis, Allergic Contact; Erythrocytes; Hypersensitivity, Delayed; Immunosuppression Therapy; Interleukin-10; Isomerism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Oxazolone; Sheep; Signal Transduction; Skin; Specific Pathogen-Free Organisms; Spleen; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Ultraviolet Rays; Urocanic Acid | 1996 |